skip to primary navigation skip to content

Claudia Schneider

Winton Centre for Risk and Evidence Communication

People

Dr Claudia R. Schneider

Claudia 3.jpg

Claudia Schneider received her PhD in Psychology from Columbia University in 2018. Her research focuses on how quality of evidence and the uncertainty around claims stemming from factors such as expert disagreement or biases in reporting are best communicated to support comprehension, transparent information sharing, and informed decision making. She investigates these topics across a range of fields, such as medical decision making, climate change and conservation, education and social policy, as well as intelligence and law. Claudia is also interested in human prosociality as related to society-level issues, such as climate change and intergroup conflict. She studies how social and individual factors interplay to bring about and shape prosocial behaviours, as for instance climate change mitigation actions or support of members of marginalised societal groups. She uses a combination of methods ranging from quantitative surveys to field studies.

Can You Handle the Evidence?

Test your skill at navigating evidence-by-numbers with one of our quick quizzes.

Journalists & Press Officers
Do you know your absolute from your relative risks? Your ORs from your HRs? Test yourself here.
Medical Professionals
You know the difference between sensitivity and specificity, but what about lead-time and overdiagnosis bias? Examine yourself here.
Legal Professionals
Given a positive DNA match, what’s the likelihood of innocence? Check your grasp of forensic evidence & probability here.

Latest news

Latest data from the MHRA on blood clots associated with the Astra Zeneca COVID-19 vaccine

7 May 2021

We've produced some new graphics to illustrate the data released on 6th May 2021 on blood clots and the AstraZeneca vaccine from the MHRA

Risky Talk - Communicating Evidence to Policymakers

26 April 2021

Politicians and civil servants are hungry for data to help design effective policy. How do we best collect and communicate this evidence - to support good governance and public accountability? …

Communicating the potential benefits and harms of the Astra-Zeneca COVID-19 vaccine

7 April 2021

Please note this article dates from 7th April 2021. New data from the MHRA and falling incidence of COVID-19 in the UK mean that these illustrations are no longer current. …

View all news